Jonas Cicenas PhD biochemistry (Universität Basel); PhD student (East Carolina University); MSc biology (Lietuvos edukologijos universitetas); BSc biology (Lietuvos edukologijos universitetas)
Assistant Professor, Kauno Kolegija, Kaunas · Lithuania
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Kinases
- Cancer
- Gdpases
- Bioinformatics
- Biostatistics
- Biocuration
Biography
Dr. Jonas Cicenas, PhD, MSc, BSc, is an Assistant Professor at Kauno Kolegija in Kaunas, Lithuania. He received his academic training from institutions including Universität Basel, East Carolina University, and Lietuvos edukologijos universitetas. His research focuses on kinases, cancer biology, GDPases, bioinformatics, and biostatistics. Dr. Cicenas has authored over 12 indexed publications, including his most-cited work, "KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer" (2017), which has received 214 citations and reflects his contributions to understanding the molecular genetics of cancer.
Selected publications
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer 2017 cited 214×
- Kinases and Cancer 2018 cited 148×
- KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma 2017 cited 113×
- Highlights of the Latest Advances in Research on CDK Inhibitors 2014 cited 112×
- Non-Coding RNAs in Glioma 2018 cited 101×
- JNK, p38, ERK, and SGK1 Inhibitors in Cancer 2017 cited 95×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Jonas Cicenas (Assistant Professor, Kauno Kolegija, Kaunas) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.